Antibodies to amyloid beta

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9834598
SERIAL NO

14435520

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDIMMUNE LIMITEDMILSTEIN BUILDING GRANTA PARK CAMBRIDGE CB21 6GH UNITED KINGDOM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Freskgärd, Per-Ola Södertälje, SE 4 8
Groves, Maria Cambridge, GB 10 10
Gustavsson, Suzanne Huddinge, SE 5 8
Höglund, Kina Solna, SE 6 8
Lloyd, Chris Cambridge, GB 6 20
Lowne, David Cambridge, GB 5 8
Nickson, Adrian Cambridge, GB 5 8
Niva, Camilla Arsta, SE 5 8
Simon, Sylvia Stockholm, SE 5 8
Welsh, Fraser Cambridge, GB 8 63

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 5, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 5, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00